Lymphoblastic Leukemia, Acute, Childhood Completed Phase 1 Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0044925 (Lymphoblastic Leukemia, Acute, Childhood)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01861002A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AMLTreatment